top of page

Aging Reimagined
Caren Pharma is pioneering novel hormone-based
approaches to combat age-related diseases 


Hormones have the potential to revolutionize aging, but are largely avoided due to perceived risks

Problem Restated

Deeper dives into the literature shows that the true culprit behind these risks is not being addressed


Our patented combinations unlock hormones' therapeutic benefits while preventing risks

Caren Pharma is a preclinical stage bio-pharma with a
platform of therapeutics to combat age-related diseases

About: Our Story

Our Story

Ed Friedman, PhD (U of Chicago) has been a Theoretical Biologist for nearly 30 years. By independently analyzing thousands of publications, Ed became a world expert on hormone receptors. He wrote a book, spoke at several conferences, and published 14 letters and articles (here).

In 2019, his son, David Friedman, was working in Finance when when he began exploring Ed’s scientific model. David recognized that this science could help millions of people. Caren Pharma was formed to make that a reality.

About: Caren Pharma

Management Team

Ed Friedman Headshot.png

Ed Friedman, PhD

Co-Founder, Chief Scientific Officer

David Friedman Headshot.jpg

David Friedman

Co-Founder, Chief Executive Officer

Home: Our Team
Home: Contact

Contact Us

Your message was sent!

bottom of page